CLS B — Clinical Laserthermia Systems AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK108.71m
- SEK91.60m
- SEK8.27m
Annual cashflow statement for Clinical Laserthermia Systems AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | R2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | PRESS | ARS | Interim Report | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0 | — | — | 0.073 | 0.304 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -39.1 | -54.4 | -66.2 | -68.1 | -66.4 |
| Capital Expenditures | 0 | -0.546 | -0.555 | -0.562 | -5.58 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.04 | 0.038 | 0.147 | -0.324 | 0 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.04 | -0.508 | -0.408 | -0.886 | -5.58 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 20.3 | 62 | 85.9 | 48.5 | 76.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -18.7 | 7.1 | 19.3 | -20.6 | 4.74 |